Brief: Medincell Q1 2026 U.S. Net Sales Reached $63 Million
April 29 (Reuters) - Medincell SA MEDCL.PA: UZEDY Q1 2026 U.S. NET SALES REACHED $63 MILLION, UP 62% YEAR-ON-YEAR ELIGIBLE FOR UP TO $105 MILLION IN COMMERCIAL MILESTONE PAYMENTS ON UZEDY SALES EUROPEAN MAA ACCEPTANCE FOR OLANZAPINE LAI EXPECTED IN Q2 2026 Source text: ID:nBwjM4lHa Further company coverage: MEDCL.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))